
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
The rate of measles cases in the United States for 2019 has climbed to numbers unheard of in decades. Here are 10 facts to know and share with the parents in your practice about measles.






